Mast cell tumors are prevalent skin neoplasms observed in veterinary clinical practice, particularly affecting both dogs and cats. Over the years, rigorous ...

Akston, the Biotech Built for Pets, in partnership with Purdue University and its College of Veterinary Medicine, announced today that it has initiated a clinical study to evaluate a first–in–class ...

The Ambifect version of the new trial drug builds on Akston's anti-cPD-L1 mAb, designed to target and block the cPD-L1 protein on cancer cells, which is currently in clinical trial for dogs with ...

Emerging therapies such as bezuclastinib and elenestinib show promise in improving disease control with potentially fewer toxicities. Other novel strategies, such as immune-based therapies, are under ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Mast cell activation disorders (MCAD) encompass a wide range of immune-mediated conditions characterized by episodic or chronic mast cell activation, ...

A large study in pet dogs has uncovered potential new biomarkers of aging that could one day help both dogs and humans live longer, healthier lives. Scientists have long searched for biological ...

Scientists found that nearly every cancer harbors its own distinct community of microbes – tiny passengers that can influence how tumors start, spread, and respond to treatment, paving the way for a ...

M Miriam Merad’s fascination with macrophages began when she looked into the lungs of a cancer patient she’d just lost during ...

Caribou Biosciences said its off-the-shelf CAR-T therapy induced complete and durable remissions in patients with advanced ...

Frailty threatens older individuals because it increases their vulnerability to detrimental health outcomes, such as falling, ...